drug_type
RELEVANT_DRUG
intervention_type
Drug (bispecific antibody–drug conjugate)
drug_description
IgG-based bispecific antibody–drug conjugate targeting HER3 (ERBB3) and TROP2; binds tumor cells, induces receptor-mediated internalization, and releases an intracellular cytotoxic payload to kill cancer cells, potentially dampening HER3 signaling and addressing antigen heterogeneity.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
ANTIBODY DRUG CONJUGATE
drug_class
Conjugate
drug_delivery_route
Intravenous
drug_mechanism_of_action
IgG-based bispecific antibody–drug conjugate that binds HER3 (ERBB3) and TROP2 on tumor cells, induces receptor-mediated internalization, and releases an intracellular cytotoxic payload to kill cancer cells; dual targeting may also dampen HER3 signaling and address antigen heterogeneity.
drug_name
JSKN016
nct_id_drug_ref
NCT06592417